News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
558,307 Results
Type
Article (45158)
Company Profile (125)
Press Release (513024)
Section
Business (155175)
Career Advice (2402)
Deals (29005)
Drug Delivery (113)
Drug Development (71131)
Employer Resources (148)
FDA (15767)
Job Trends (12441)
News (278438)
Policy (30463)
Tag
Academia (2348)
Alliances (36875)
Alzheimer's disease (1364)
Approvals (15698)
Artificial intelligence (169)
Bankruptcy (309)
Best Places to Work (9648)
Breast cancer (205)
Cancer (1536)
Cardiovascular disease (130)
Career advice (2002)
CAR-T (111)
Cell therapy (319)
Clinical research (57052)
Collaboration (528)
Compensation (312)
COVID-19 (2612)
C-suite (133)
Data (1427)
Diabetes (196)
Diagnostics (5378)
Drug pricing (111)
Earnings (64913)
Employer resources (136)
Events (89970)
Executive appointments (472)
FDA (16568)
Funding (475)
Gene therapy (234)
GLP-1 (713)
Government (4063)
Healthcare (15542)
Infectious disease (2712)
Inflammatory bowel disease (110)
Interviews (446)
IPO (14480)
Job creations (3196)
Job search strategy (1668)
Layoffs (473)
Legal (7146)
Lung cancer (230)
Manufacturing (215)
Medical device (11485)
Medtech (11488)
Mergers & acquisitions (14803)
Metabolic disorders (559)
Neuroscience (1755)
NextGen: Class of 2025 (5197)
Non-profit (3368)
Northern California (1806)
Obesity (328)
Opinion (204)
Patents (137)
People (43701)
Phase I (16914)
Phase II (24805)
Phase III (20196)
Pipeline (641)
Postmarket research (2376)
Preclinical (6962)
Radiopharmaceuticals (215)
Rare diseases (309)
Real estate (4397)
Regulatory (20947)
Research institute (2094)
Resumes & cover letters (402)
Southern California (1534)
Startups (2816)
United States (15647)
Vaccines (662)
Weight loss (254)
Date
Last 7 days (557)
Last 30 days (2411)
Last 365 days (31877)
2025 (2491)
2024 (32372)
2023 (36360)
2022 (46518)
2021 (50204)
2020 (47191)
2019 (38128)
2018 (28868)
2017 (28814)
2016 (27344)
2015 (30613)
2014 (24111)
2013 (19571)
2012 (21040)
2011 (21511)
2010 (19456)
Location
Africa (678)
Arizona (158)
Asia (32052)
Australia (5600)
California (4058)
Canada (1267)
China (307)
Colorado (181)
Connecticut (207)
Europe (77531)
Florida (589)
Georgia (139)
Illinois (363)
Indiana (209)
Maryland (664)
Massachusetts (3138)
Michigan (157)
Minnesota (280)
New Jersey (1161)
New York (1147)
North Carolina (757)
Northern California (1806)
Ohio (132)
Pennsylvania (913)
South America (1045)
Southern California (1534)
Texas (567)
Utah (111)
Washington State (403)
558,307 Results for "philogen s p a".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Philogen enters into a Service and Supply Agreement with IBSA for the GMP Production of a Therapeutic Protein
Philogen S.p.A announced that it has entered into a Service and Supply Agreement with IBSA to produce a recombinant therapeutic protein at Philogen GMP Facilities in Siena.
June 28, 2023
·
4 min read
Philogen Announces Clinical Trial Collaboration with MSD
Philogen S.p.A. announces that it has entered into a Clinical Trial Collaboration and Supply Agreement with MSD.
June 1, 2023
·
3 min read
Business
Sun Pharma and Philogen enter into an Exclusive Distribution, License, and Supply Agreement for Commercializing specialty product, NIDLEGY™ in Europe, Australia and New Zealand
Sun Pharmaceutical Industries Limited and Philogen S.p.A announced that they have entered into a licensing agreement for commercializing Philogen’s specialty product, Nidlegy™ in the territories of Europe, Australia and New Zealand.
May 30, 2023
·
5 min read
Press Releases
David P. King Joins Truvian’s Advisory Board
January 13, 2025
·
2 min read
Philogen Publishes New Data on a Fibromun-based treatment combination in Science Translational Medicine in collaboration with the University Hospital Zürich
Philogen S.p.A. announces the publication of the latest results of Fibromun in combination with lomustine for the treatment of glioblastoma in Science Translational Medicine describing how the combination treatment cured orthotopic glioma-bearing mice and mediated durable objective responses and major tumor shrinkage in patients with recurrent glioblastoma.
May 25, 2023
·
10 min read
Press Releases
Acadia Pharmaceuticals Set to Join S&P SmallCap 600
December 31, 2024
·
1 min read
Press Releases
Haemonetics Completes Sale of Whole Blood Assets to GVS, S.p.A
January 14, 2025
·
4 min read
Press Releases
Azafaros to Present at J.P. Morgan’s 43rd Annual Healthcare Conference
January 9, 2025
·
3 min read
Press Releases
Axxam S.p.A. accelerates global expansion incorporating Axxam Inc.
December 13, 2024
·
2 min read
Philogen to Present at UBS Global Healthcare Conference
Philogen S.p.A. today announces that it will present at the UBS Global Healthcare Conference on May 25, 2022 at the Lotte New York Palace.
May 5, 2022
·
2 min read
1 of 55,831
Next
